UBS Group AG

Holdings History for Corbus Pharmaceuticals Holdings, Inc. - Common Stock, $0.0001 par value (CRBP)

Symbol: CRBP on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	-0%	$416,842	51,209	-8,287	-14%	$8.14	Q4 2025
30 Sep 2025	0%	-0%	$752,624	59,496	-32,347	-35%	$12.65	Q3 2025
30 Jun 2025	0%	+0%	$633,717	91,843	+999	+1.1%	$6.90	Q2 2025
31 Mar 2025	0%	+0%	$482,383	90,844	+1,467		$5.31	Q1 2025
31 Dec 2024	0%	+0%	$1,054,648	89,377	+65,162	+269%	$11.80	Q4 2024
30 Sep 2024	0%	+0%	$499,555	24,215	+2,566	+12%	$20.63	Q3 2024
30 Jun 2024	0%	+0%	$979,617	21,649	+6,184	+40%	$45.25	Q2 2024
31 Mar 2024	0%	+0%	$606,846	15,465	+15,144	+4718%	$39.24	Q1 2024
31 Dec 2023	0%	-0%	$1,939	321	-861	-73%	$6.04	Q4 2023
30 Sep 2023	0%	+0%	$7,967	1,182	+879	+290%	$6.74	Q3 2023
30 Jun 2023	0%	-0%	$2,375	303	-4,541	-94%	$7.84	Q2 2023
31 Mar 2023	0%	+0%	$35,216	4,844	+4,844	NEW	$7.27	Q1 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.